A missed opportunity: underutilization of inpatient behavioral health services to reduce injection drug use sequelae in Florida
- PMID: 34059104
- PMCID: PMC8167948
- DOI: 10.1186/s13011-021-00383-w
A missed opportunity: underutilization of inpatient behavioral health services to reduce injection drug use sequelae in Florida
Abstract
Background: People who inject drugs (PWID) suffer high morbidity and mortality from injection related infections (IRI). The inpatient setting is an ideal opportunity to treat underlying substance use disorder (SUD), but it is unclear how often this occurs.
Objectives: To quantify the utilization of behavioral health services for PWID during inpatient admissions for IRI.
Methods: Data for all hospital admissions in Florida in FY2017 were obtained from the Agency for Healthcare Administration. Hospitalization for IRI were obtained using a validated ICD-10 algorithm and treatment for substance use disorder was quantified using ICD-10-Procedure Coding System (ICD-10-PCS) codes.
Result: Among the 20,001 IRI admissions, there were 230 patients who received behavioral health services as defined by ICD-10-PCS SAT codes for treatment for SUD.
Conclusions: In a state with a large number of IRI, only a very small portion of admissions received behavioral health services. Increased efforts should be directed to studying referral patterns among physicians and other providers caring for this population and increasing utilization of behavioral health services.
Keywords: Addiction; Inpatient addiction services; MOUD; Opioids; People who inject drugs.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Hospital admissions among people who inject opioids following syringe services program implementation.Harm Reduct J. 2020 May 12;17(1):30. doi: 10.1186/s12954-020-00376-1. Harm Reduct J. 2020. PMID: 32398059 Free PMC article.
-
Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.Int J Drug Policy. 2018 May;55:31-39. doi: 10.1016/j.drugpo.2018.02.001. Epub 2018 Feb 23. Int J Drug Policy. 2018. PMID: 29482150
-
Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.PLoS One. 2019 Nov 26;14(11):e0225460. doi: 10.1371/journal.pone.0225460. eCollection 2019. PLoS One. 2019. PMID: 31770395 Free PMC article.
-
Acute injection-related infections requiring hospitalisation among people who inject drugs: Clinical features, microbiology and management.Drug Alcohol Rev. 2022 Nov;41(7):1543-1553. doi: 10.1111/dar.13525. Epub 2022 Aug 22. Drug Alcohol Rev. 2022. PMID: 36053863 Free PMC article. Review.
-
Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review.Int J Drug Policy. 2019 Oct;72:146-159. doi: 10.1016/j.drugpo.2019.05.023. Epub 2019 May 27. Int J Drug Policy. 2019. PMID: 31147142
Cited by
-
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.Addict Sci Clin Pract. 2023 Feb 7;18(1):8. doi: 10.1186/s13722-023-00363-4. Addict Sci Clin Pract. 2023. PMID: 36747268 Free PMC article.
References
-
- Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, Holtzman D. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175–181. doi: 10.2105/AJPH.2017.304132. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials